로딩 중…
지수 로딩 중…
Corvus Pharmaceuticals, Inc.
CRVS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$13.37+0.83%
2026-08-03
Financials
Valuation Metrics
Corvus Pharmaceuticals, Inc.'s Market Cap is $1.12B. At end of 2025 it was $608M. Ranked #2441 of 3,112 in US market (top 78%), #988 of 1,445 on NASDAQ (top 68%), #184 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 68%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.12B | US#2,441/3,112 Sec#184/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-44M | US—/3,112 Sec—/269 |
| Total Assets | $253M | US#2,941/3,112 Sec#233/269 |
| Net Assets | $241M | US#2,655/3,112 Sec#179/269 |
| Value | ||
| P/B | 4.67x | US#2,113/3,112 Sec#135/269 |
| FCF Yield | -3.13% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -18.35% | US#2,508/3,112 Sec#99/269 |
| ROA | -17.44% | US#2,752/3,112 Sec#117/269 |
| Earnings Growth | -190.12% | US#2,222/3,112 Sec#79/269 |
| Financial Health | ||
| Debt Ratio | 5.20% | US#51/3,112 Sec#21/269 |
| Total Debt | $834000.00 | US#2,936/3,112 Sec#248/269 |
| FCF | $-35M | US#2,432/3,112 Sec#106/269 |
| Cash | $40M | US#2,666/3,112 Sec#237/269 |
| Current Ratio | 19.81x | US#127/3,112 Sec#33/269 |
| Performance | ||
| 1Y Return | 226.10% | US#96/3,112 Sec#29/269 |
| 1M Return | -12.21% | US#2,706/3,112 Sec#187/269 |
| From 52W High | -50.39% | US#2,790/3,112 Sec#220/269 |
| 1Y MDD | -56.43% | US#2,630/3,112 Sec#204/269 |
| Trading | ||
| Volume | 547,834 shares | US#1,998/3,112 Sec#194/269 |
| Trading Value | $7M | US#2,511/3,112 Sec#202/269 |
| Per Share | ||
| EPS | $-0.19 | US—/3,112 Sec—/269 |
| BPS | $0.78 | US#2,651/3,112 Sec#209/269 |